Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
GraphiteRx
AddedFeb 17, 2024
UpdatedJun 18, 2026
GraphiteRx

GraphiteRx

Seed

Modern pharmacy marketplace streamlining procurement and distribution.

HQ
Nashville, TN, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

GraphiteRx, founded with the mission to revolutionize pharmacy procurement and distribution, offers a modern marketplace platform designed to streamline these processes for hospitals, pharmacies, and clinics. The company's vision is to increase access to pharmaceuticals and medical supplies while reducing costs, particularly for smaller manufacturers who face high distribution expenses with traditional wholesalers. GraphiteRx focuses on creating an efficient and cost-effective supply chain in the healthcare market.

Notable affiliated people and investors include industry experts and venture capitalists committed to healthcare innovation. Key achievements of GraphiteRx include successfully partnering with various healthcare providers and suppliers, enhancing their procurement efficiency, and significantly lowering operational costs. The overall impact of GraphiteRx has been substantial in making pharmaceutical distribution more accessible and affordable, thereby contributing to improved healthcare delivery.

GraphiteRx - Similar Companies

InStockRx logo

InStockRx

instockrx.com

RxPlace logo

RxPlace

myrxplace.com

Pharmly logo

Pharmly

SmithRx logo

SmithRx

smithrx.com

GeniusRx logo

GeniusRx

geniusrx.com

Capital Rx logo

Capital Rx

cap-rx.com

RxLive logo

RxLive

rxlive.com

NimbleRx logo

NimbleRx

nimblerx.com

Rx Delivered Now logo

Rx Delivered Now

rxdeliverednow.com

Health Haven Rx logo

Health Haven Rx

healthhavenrx.com

InvoCure logo

InvoCure

invocure.com

RxNetwork logo

RxNetwork

ScriptAssist Pharmacy logo

ScriptAssist Pharmacy

scriptassistrx.com

Gifthealth logo

Gifthealth

gifthealth.com

RxVantage logo

RxVantage

rxvantage.com

GraphiteRx - Quick Facts

Who are GraphiteRx's competitors?

Companies similar to GraphiteRx include InStockRx, RxPlace, Pharmly and SmithRx.

When was GraphiteRx founded?

GraphiteRx was founded in 2018.

Where is GraphiteRx's headquarters located?

GraphiteRx's headquarters is located in Nashville, TN, US.

When was GraphiteRx's last funding round?

GraphiteRx's most recent funding round was for $2.5M (USD) in September 2019.

How much has GraphiteRx raised to-date?

As of Sep 25, 2019, GraphiteRx has raised a total of $2.5M (USD).

How many employees does GraphiteRx have?

GraphiteRx has 36 employees as of Feb 4, 2024.

GraphiteRx - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Enterprise
  • Small Business
Main Product
  • Pharmacy Marketplace
Tags
  • Marketplace
  • SaaS
NAICS
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 3 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 5900Miscellaneous Retail
  • 5910Drug Stores And Proprietary Stores